-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-nursing-home-characteristics_research-protocol.pdf
November 03, 2011 - industry-funded
projects on: (a)family involvement, (b) end of life care and outcomes, (c)
medication prescribing
-
effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research-protocol
November 22, 2011 - Current Page Topic Timeline Aug. 4, 2010 Topic Suggestion Nov. 22, 2011 Research Protocol Sep. 25, 2013 Systematic Review Feb. 13, 2014 Disposition of Comments Report Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment
Research Protocol Archived November 22, 2011 Download Main Do…
-
effectivehealthcare.ahrq.gov/products/major-depressive-disorder/research-protocol
June 19, 2014 - Current Page Topic Timeline Mar. 11, 2013 Topic Suggestion Jun. 19, 2014 Research Protocol Dec. 8, 2015 Systematic Review May. 5, 2016 Disposition of Comments Report Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder
Research Protocol Archived June 19, 2014 Downl…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bipolar-disorder-treatment_research-protocol.pdf
June 23, 2014 - bipolar-disorder-treatment-protocol-140623
Evidence-based Practice Center Systematic Review Protocol
Project Title: Treatment for Bipolar Disorder
I. Background and Objectives for the Systematic Review …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
September 01, 2011 - Layout 1
Background
Gastroesophageal reflux disease (GERD) is
one of the most common health conditions
affecting Americans. A study of an
employed population in the United States
estimated that more than 11,000 of 267,000
employees (4 percent) suffered from
GERD, contributing an average
incremental cost to the emplo…
-
effectivehealthcare.ahrq.gov/sites/default/files/selection-of-data-sources-chapter-8.pptx
January 01, 2013 - Are there any differences in availability, cost, practice, or prescribing guidelines between the study
-
effectivehealthcare.ahrq.gov/products/osteoarthritis-pain/research-protocol
August 05, 2010 - selective serotonin reuptake inhibitors (SSRI)
Question 3
What are the comparative effects of co-prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-ems-protocol-amendment.pdf
January 28, 2019 - Opioid prescribing in a cross section of US
emergency departments.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
January 30, 2014 - National Hospital Ambulatory Medical Care Survey, Cooper
and colleagues28 demonstrated that antipsychotic prescribing … Furthermore, the medication prescribing increases were greater for non-approved
indications including … Trends in prescribing of antipsychotic medications
for US children. Ambul Pediatr. 2006;6:79-83.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
January 01, 2019 - portraying
pharyngitis
2008 AMIA Annu Symp Proc
19025425 Prioritizing future research on off-label prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
December 30, 2015 - Infection is currently listed in official
prescribing information as a common risk of several
hypnotics
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gaps-womens-health-22.pdf
April 01, 2022 - studies on harms of
opioid therapy for chronic pain, different opioids or
formulations, and different prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
September 01, 2012 - PMID: 17890196 [PubMed—indexed for MEDLINE]
Obtain
Results of a 12-month quality-circle prescribing … Rennes, France. francoise.riou@univ-
rennes1.fr
BACKGROUND: The impact of a quality-circle GP prescribing … Practice data (overall prescribing cost and
markers of prescribing efficiency) were collated in an
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-classification_research.pdf
December 01, 2010 - Fundholders’ prescribing costs: the first five years. BMJ
1996;313:1531-1534. … group
To determine whether the
first 5 waves of English
fundholding practices have
reduced their prescribing … nonfundholding practices
Changes and rates of
change in cost per
prescribing unit and
changes in … number of
items per prescribing unit
Herman 2001 Before-after
study
To evaluate the effect of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
March 01, 2012 - Amgen requests
that the complete indication, as specified in the Prolia®
prescribing information, be … Discussion:
Chapter 4-
Discussion
It is also potentially harmful for patients to suggest that
prescribing … If someone on
ibandronate gets a hip fracture how could a prescribing doctor
defend their position … We cannot find any place on page 160 where we say that
prescribing any of the bisphosphonates reduce
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-disposition-comments.pdf
October 25, 2022 - Evidence-based Practice Center Systematic Review Protocol - Management of Infantile Epilepsies
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Management of Infantile Epilepsies
Draft report available for public comment from July 23, 2021, to September 6, …
-
effectivehealthcare.ahrq.gov/products/renal-update/research-protocol
January 20, 2015 - Current Page Topic Timeline Jan. 15, 2015 Topic Initiated Jan. 20, 2015 Research Protocol Aug. 16, 2016 Systematic Review Dec. 20, 2016 Disposition of Comments Report Renal Artery Stenosis Update
Research Protocol Archived January 20, 2015 Download Main Document PDF 467.8 KB
Archived: This report is …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - Comparative Effectiveness Review
118
Appendix A. Pharmacokinetics, Indications and
Dosing of Included Drugs
Drug and Trade
Name
(Trade names
provided only for
drugs under
patent.)
Half-life or other
relevant
pharmacokinetic
feature
Labeled indications Dosing (oral
doses)
Dose adjustments fo…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - Research White Paper Multinational Registries Addendum Registries for Evaluating Patient Outcomes Third Edition
Research White Paper
Multinational Registries: Challenges and
Opportunities
Research White Paper
Multinational Registries: Challenges and
Opportunities
Addendum to Reg…
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - Research White Paper Multinational Registries Addendum Registries for Evaluating Patient Outcomes Third Edition
Research White Paper
Multinational Registries: Challenges and
Opportunities
Research White Paper
Multinational Registries: Challenges and
Opportunities
Addendum to Reg…